Title: Serum levels of IL-4, IL-17, IFN-γ and, TGF-β in of patients with chronic lymphocytic leukemia and the clinical significance
Abstract: Objective
To investigate the serum levels of IL-4, IL-17, IFN-γ and, TGF-β in of patients with chronic lymphocytic leukemia and the clinical significance.
Methods
40 patients first diagnosed with chronic lymphocytic leukemia at our hospital from June, 2014 to March, 2016 were selected as an initial diagnosis group, 30 patients with stable conditions after 3 months’ treatment a treatment group, and 30 healthy examinees from the same period a control group. The serum levels of IL-4, IL-17, IFN-γ and, TGF-β of the three groups were detected by ELISA method. The differences of IL-4, IL-17, IFN-γ, TGF-β, IFN-γ/IL-4, and TGF-β/IL-17 were compared among the three groups.
Results
The serum levels of IL-4 and IL-17 and TGF-β/IL-17 were significantly higher [(18.46±4.66)pg/ml vs. (12.73±5.22)pg/ml, (268.98±63.69)pg/ml vs. (135.25±78.42)pg/ml and (18.25±8.64) vs. (10.88±6.18)] and the serum level of IFN-γ and IFN-γ/IL-4 were significantly lower [(21.14±4.47)pg/ml vs. (32.58±4.54)pg/ml and (8.07±4.70) vs. (14.21±6.31)] in the initial diagnosis group than in the control group (P<0.05). The serum levels of IL-4 and IL-17 and TGF-β/IL-17 were significantly lower [(13.61±4.38)pg/ml vs. (18.46±4.66)pg/ml, (184.55±67.27)pg/ml vs. (268.98±63.69)pg/ml, and (14.43±6.52) vs. (18.25±8.64)] and the serum level of IFN-γ and IFN-γ/IL-4 were significantly higher [ (24.27±4.18) pg/ml vs. (21.14±4.47) pg/ml and (11.06±7.05) vs. (8.07±4.70) ] in the treatment group than in the initial diagnosis group (P<0.05). In the initial diagnosis group, the TGF-β/IL-17 gradually increased with Binet stage [(12.52±6.42), (17.66±8.37), (21.30±10.74)] and the IFN-γ/IL-4 gradually decreased with Binet stage [(10.22±2.85), (9.09±3.05), (7.78±2.46)], showing obvious relevance (P<0.05).
Conclusions
IFN-γ/IL-4 and TGF-β/IL-17 can obviously indicating the conditions of patients with chronic lymphocytic leukemia and be used as important clinical indexes for the disease progression and prognosis prediction in CLL patients.
Key words:
Chronic lymphocytic leukemia; IL-4; IL-17; IFN-γ; TGF-β; Prognosis prediction
Publication Year: 2017
Publication Date: 2017-03-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot